Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: Cancer Lett. 2021 Apr 7;509:39–52. doi: 10.1016/j.canlet.2021.03.031

Figure 2. Patient-Derived Organoids to Model Esophageal Cancer.

Figure 2.

Hematoxylin and Eosin stained sections of fixed 3D organoids derived from the non-transformed human esophageal epithelial EPC2-hTERT cell line, and from ESCC, BE, and EAC PDO lines derived from human patient biopsies.